Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Akerna Corp.

KERNWNASDAQ
Healthcare
Medical - Healthcare Information Services
$0.001
$0.00(40.00%)
U.S. Market opens in 11h 19m

Akerna Corp. Fundamental Analysis

Akerna Corp. (KERNW) shows weak financial fundamentals with a PE ratio of -15.93, profit margin of -22.77%, and ROE of -12.72%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position1266.94%
PEG Ratio-10.03

Areas of Concern

ROE-12.72%
Operating Margin-15.40%
Current Ratio0.07
We analyze KERNW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -15.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-15.9/100

We analyze KERNW's fundamental strength across five key dimensions:

Efficiency Score

Weak

KERNW struggles to generate sufficient returns from assets.

ROA > 10%
-1.52%

Valuation Score

Excellent

KERNW trades at attractive valuation levels.

PE < 25
-15.93
PEG Ratio < 2
-10.03

Growth Score

Weak

KERNW faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

KERNW shows balanced financial health with some risks.

Debt/Equity < 1
0.32
Current Ratio > 1
0.07

Profitability Score

Weak

KERNW struggles to sustain strong margins.

ROE > 15%
-1272.16%
Net Margin ≥ 15%
-22.77%
Positive Free Cash Flow
No

Key Financial Metrics

Is KERNW Expensive or Cheap?

P/E Ratio

KERNW trades at -15.93 times earnings. This suggests potential undervaluation.

-15.93

PEG Ratio

When adjusting for growth, KERNW's PEG of -10.03 indicates potential undervaluation.

-10.03

Price to Book

The market values Akerna Corp. at 0.49 times its book value. This may indicate undervaluation.

0.49

EV/EBITDA

Enterprise value stands at 44.10 times EBITDA. This signals the market has high growth expectations.

44.10

How Well Does KERNW Make Money?

Net Profit Margin

For every $100 in sales, Akerna Corp. keeps $-22.77 as profit after all expenses.

-22.77%

Operating Margin

Core operations generate -15.40 in profit for every $100 in revenue, before interest and taxes.

-15.40%

ROE

Management delivers $-12.72 in profit for every $100 of shareholder equity.

-12.72%

ROA

Akerna Corp. generates $-1.52 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.52%

Following the Money - Real Cash Generation

Operating Cash Flow

Akerna Corp. generates limited operating cash flow of $-11.55M, signaling weaker underlying cash strength.

$-11.55M

Free Cash Flow

Akerna Corp. generates weak or negative free cash flow of $-11.55M, restricting financial flexibility.

$-11.55M

FCF Per Share

Each share generates $-0.05 in free cash annually.

$-0.05

FCF Yield

KERNW converts -275.93% of its market value into free cash.

-275.93%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-15.93

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-10.03

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.49

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.002

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.32

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.07

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.13

vs 25 benchmark

ROA

Return on assets percentage

-0.02

vs 25 benchmark

ROCE

Return on capital employed

-0.01

vs 25 benchmark

How KERNW Stacks Against Its Sector Peers

MetricKERNW ValueSector AveragePerformance
P/E Ratio-15.9329.28 Better (Cheaper)
ROE-12.72%820.00% Weak
Net Margin-22.77%-19731.00% (disorted) Weak
Debt/Equity0.320.26 Weak (High Leverage)
Current Ratio0.074.69 Weak Liquidity
ROA-1.52%-17993.00% (disorted) Weak

KERNW outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Akerna Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ